OTC Markets EXMKT - Delayed Quote USD
Manhattan Scientifics, Inc. (MHTX)
0.0001
+0.0001
(0.00%)
As of April 25 at 4:00:00 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Marvin Maslow | Founder & Chairman of the Board | -- | -- | 1938 |
| Mr. Emmanuel Tsoupanarias | President, CEO & Director | 186k | -- | 1953 |
| Mr. Leonard C. Friedman | Secretary | -- | -- | 1938 |
| Mr. Robert Romeo Proulx | President of Imagion | 250k | -- | 1958 |
Manhattan Scientifics, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
Description
Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.
Corporate Governance
Manhattan Scientifics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 29, 2025 at 10:59 AM UTC - May 6, 2025 at 12:00 PM UTC
Manhattan Scientifics, Inc. Earnings Date